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Background: There are data to suggest that anemia is associated with increased mortality in 
patients with chronic obstructive pulmonary disease (COPD). In contrast, critically ill patients 
with low hemoglobin levels (4.3–5.5 mmol/L, 7.0–9.0 g/dL) in general do not appear to have 
a worsened clinical outcome. The effects of anemia in critically ill patients with COPD remain 
to be clarified. We examined the association between anemia (hemoglobin ,7.4 mmol/L, 
,12.0 g/dL) and 90-day mortality in COPD patients with acute respiratory failure treated with 
invasive mechanical ventilation in a single-institution follow-up study.
Method: We identified all COPD patients at our institution (n = 222) admitted for the first time 
to the intensive care unit (ICU) requiring invasive mechanical ventilation in 1994–2004. Data 
on patient characteristics (eg, hemoglobin, pH, blood transfusions, and Charlson Comorbidity 
Index), and mortality were obtained from population-based clinical and administrative registries 
and medical records. We used Cox’s regression analysis to estimate mortality rate ratios (MRR) 
in COPD patients with and without anemia.
Results: A total of 42 (18%) COPD patients were anemic at time of initiating invasive mechani-
cal ventilation. The overall 90-day mortality among anemic COPD patients was 57.1% versus 
25% in nonanemic patients. The corresponding adjusted 90-day MRR was 2.6 (95% confidence 
interval 1.5–4.5). Restricting analyses to patients not treated with blood transfusions during 
their intensive care unit stay did not materially change the MRR.
Conclusion: We found anemia to be associated with increased mortality among COPD patients 
with acute respiratory failure requiring invasive mechanical ventilation.
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Background
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity,   disability, 
and mortality worldwide.1 Patients with advanced COPD are often hospitalized for 
acute respiratory failure and may require invasive mechanical ventilation, which is 
associated with high inhospital mortality rates ranging from 6% to 24%.2–9 Limited 
and inconsistent data exist on simple, readily available predictors of mortality in criti-
cally ill COPD patients requiring invasive mechanical ventilation. Emerging informa-
tion from studies and reports describes increased morbidity and mortality in anemic 
patients with COPD.10–15 In contrast, studies of transfusion regimens have found that 
critically ill patients in the intensive care unit (ICU) appear to tolerate low hemoglobin 
levels (4.3–5.5 mmol/L, 7.0–9.0 g/dL), with the possible exception of patients with 
acute angina or myocardial infarction who appear to have improved survival if the 
hemoglobin is kept at a somewhat higher level (6.2–6.9 mmol/L, 10.0–11.0 g/dL).15,16 It 
remains uncertain to what extent anemia is associated with clinical outcome in critically Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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ill COPD patients requiring invasive mechanical ventilation 
and how it should be managed.
We hypothesized that anemia was associated with 
increased mortality in COPD patients with acute respira-
tory failure treated with invasive mechanical ventilation and 
conducted a single-institution follow-up study to examine 
this hypothesis.
Methods
The study was conducted between January 1994 and 
December 2004 in patients admitted to the ICU at Silkeborg 
  Hospital, Denmark. The hospital services a population of 
about 100,000. In Denmark, all critically ill patients are 
treated at public hospitals. The Danish Civil Registration 
System keeps electronic records on gender, date of birth, 
change of address, date of emigration, and changes in vital 
status since 1968. The records carry a unique 10-digit civil 
registration number, assigned at birth by the Civil Registra-
tion System, which is used in all public Danish registers, 
enabling unambiguous record linkage between them.
Patients with COPD
All patients admitted to the ICU were consecutively registered 
in a local clinical database.17 The registered data included 
cause of referral, main categories of disease, complications, 
and treatment. All patients older than 35 years admitted for 
the first time to our ICU with acute respiratory failure and 
requiring invasive mechanical ventilation were identified in 
the database. We only included each patient’s first admis-
sion during the study period in order to ensure independence 
between the events, although some patients had multiple 
admissions to the ICU during the study period. We reviewed 
all medical records of these patients to identify those with 
a verified diagnosis of COPD. COPD was defined accord-
ing to The Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) criteria based on pulmonary test results, if 
a test was performed within one year prior to ICU admission. 
However, the majority of patients did not have a pulmonary 
test performed within one year before ICU admission, thus 
we also had to rely on characteristic findings in the history 
and physical examination by the attending physician at the 
time of ICU admission, as is often done in studies of COPD. 
The decision to initiate invasive mechanical ventilation was 
taken by the ICU physicians treating the patient and based 
on departmental guidelines. Similarly, overall treatment and 
extubation decisions were made at the discretion of the ICU 
team. The ICU was staffed by the same group of consultants 
during the study period.
hemoglobin, ph, and blood transfusions
We obtained data on hemoglobin levels and arterial blood 
gas pH taken before initiation of mechanical ventilation from 
the medical records. Only arterial blood gas measurements 
obtained six hours or less before intubation were considered 
relevant. All blood gas analyses were done using Radiometer 
ABL 3, 520, or 725 analyzers (Radiometer, Copenhagen, 
Denmark). We decided to make the cutoff point for anemia as 
set by the hospital laboratory, ie, hemoglobin ,7.4 mmol/L 
(,12.0 g/dL) for both men and women. Three levels of 
hemoglobin were defined: hemoglobin ,7.4 mmol/L 
(,12.0 g/dL, anemia); 7.4–9.3 mmol/L (12.0–15.0 g/dL, 
normal); hemoglobin .9.3 mmol/L (15.0 g/dL, high). Data 
on blood transfusions received during the ICU stay were 
obtained from the hospital transfusion service database.
Comorbidity
The Hospital Discharge Registry of Aarhus County contains 
data on all hospitalizations from nonpsychiatric hospitals 
in the county since 1977, including dates of admission and 
discharge, and up to 20 discharge diagnoses assigned by the 
treating physician and coded according to the International 
Classification of Diseases, 8th revision (ICD-8) until the 
end of 1993, and 10th revision (ICD-10) thereafter. We 
computed the comorbidity index score developed by Charlson 
et al18 for each patient, based on discharge diagnoses from 
the Discharge Registry registered before the date of ICU 
admission. The Charlson Comorbidity Index has previously 
been validated for the prediction of short-term and long-term 
mortality in critically ill patients.19 Diagnoses of COPD were 
excluded from the index because they defined our cohort.
Mortality
Complete follow-up data for death, emigration, or immi-
gration were obtained through linkage to the Danish Civil 
Registration System.
statistical analysis
Follow-up extended for 90 days after ICU admission, until 
death or migration, whichever came first. We analyzed data by 
obtaining contingency tables for cumulative mortality based 
on Kaplan-Meier estimates and the main study variables, ie, 
hemoglobin groups, pH, comorbidity, gender, and age. We 
used Cox’s regression analysis to compute mortality rate 
ratios (MRR) 90 days after ICU admission according to the 
three levels of hemoglobin adjusted for gender, age, Charlson 
Comorbidity Index score (0 [low], 1–2 [medium], and .2 
[high]), and pH (,7.15, 7.15–7.30, and .7.30). Because Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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there is no clear definition of anemia in critically ill patients, 
we repeated the analyses using alternative cutoff points for 
defining anemia, ie, hemoglobin ,6.2 mmol/L (10.0 g/dL) 
or ,5.5 mmol/L (9.0 g/dL). Furthermore, separate analyses 
were done according to gender and whether the patients were 
admitted in the early (before 1999) or later (after 1999) part 
of the study period.
Finally, in order to assess the impact of blood transfusion 
on our results, we repeated the regression analyses, including 
only patients who did not receive transfusion during their ICU 
stay. All risk estimates are presented with 95% confidence 
intervals (CI). All analyses were performed using the SAS 
version 8.2 (SAS Institute Inc. Cary, NC, USA).
Results
We identified 244 patients with COPD who required inva-
sive mechanical ventilation. Twenty-two patients (9%) 
were excluded because we were unable to identify their 
hemoglobin or pH values measured within six hours of ini-
tiation of invasive mechanical ventilation, leaving a total of 
222 patients available for analysis. There was no difference 
in mortality between the included and excluded patients.
The majority of patients were female (n = 122, 55%) and 
148 patients (66%) were 65 years or older (Table 1). A total 
of 42 (18%) patients had hemoglobin values lower than 
7.4 mmol/L (12.0 g/dL), 132 (60%) had hemoglobin values 
of 7.4–9.3 mmol/L (12.0–15.0 g/dL), and 48 patients (22%) 
had hemoglobin values higher than 9.3 mmol/L (15.0 g/dL). 
The most frequent comorbidity was cardiovascular disease, 
including congestive heart failure (39%) and previous acute 
myocardial infarction (11%).
The Kaplan-Meier survival curve showed a clear diver-
sion of the low hemoglobin group from the normal and high 
hemoglobin groups early after ICU admission and throughout 
the study period (see Figure 1).
The 30-day mortality was 54.8% in COPD patients with 
anemia and 19.8% in those without anemia, corresponding 
to an adjusted MRR of 3.1 (95% CI 1.6–5.9) after adjust-
ing for gender, age, comorbidity, and pH at ICU admission 
(Table 2). The 90-day mortality was 57.1% in anemic COPD 
patients and 25.0% in nonanemic COPD patients (adjusted 
MRR 2.6 [95% CI 1.5–4.5]).
Defining anemia as hemoglobin below 6.2 mmol/L 
(10.0 g/dL) yielded adjusted 30- and 90-day MRRs of 2.36 
(95% CI 0.94–5.84) and 2.42 (95% CI 1.04–5.62), respectively. 
When lowering the cutoff point to 5.5 mmol/L (9.0 g/dL), 
the adjusted 30-day and 90-day MRRs were further elevated 
to 7.79 (95% CI 2.42–5.01) and 6.81 (95% CI 2.14–21.70), 
respectively.
Furthermore, anemia was associated with higher mortality 
in both women (adjusted 90-day MRR 3.4 [95% CI 1.5–7.7]) 
and men (adjusted 90-day MRR 2.4 [95% CI 1.1–5.2]). The 
increased mortality associated with anemia was found both 
in the early adjusted 90-day MRR (3.5, 95% CI 1.6–7.5) or 
late adjusted 90-day MRR (3.1, 95% CI 1.4–7.2) part of the 
study period.
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Figure 1 survival curves according to hemoglobin levels at iCU admission for 
chronic obstructive pulmonary disease patients treated with mechanical ventilation 
[----hb , 7.4 mmol/L (12.0 g/dL); — 7.4 mmol/L (12.0 g/dL) , hb , 9.3 mmol/L 
(15.0 g/dL); ¨¨¨ hgb . 9.3 mmol/L (15.0 g/dL)].
Table 1 Descriptive characteristics of 222 chronic obstructive 
pulmonary disease patients with acute respiratory failure treated 
with  invasive  mechanical  ventilation  admitted  to  silkeborg 
hospital, Denmark 1994–2004
Hemoglobin
<7.4 mmol/L 
(12.0 g/dL) 
n (%)
7.4–9.3 mmol/L 
(12.0–15.0 g/dL) 
n (%)
>9.3 mmol/L  
(15.0 g/dL) 
n (%)
Gender  
Female  20 (9.0%) 77 (34.7%) 25 (11.3%)
Male  22 (10.0%) 55 (25.0%) 23 (10.4%)
Age (years)
,65 10 (4.5%) 49 (22.1%) 15 (6.8%)
65–75 16 (7.2%) 47 (21.2%) 26 (11.7%)
.75 16 (7.2%) 36 (16.2%) 7 (3.2%)
Comorbidity levela
Low 9 (4.1%) 53 (23.9%) 16 (7.2%)
Medium 23 (10.4%) 61 (27.5%) 26 (11.7%)
high 10 (4.5%) 18 (8.1%) 6 (2.7%)
pH
,7.15 7 (3.2%) 29 (13.1%) 9 (4.1%)
7.15–7.30 14 (6.3%) 55 (25%) 22 (10%)
.7.30 21 (9.5%) 48 (21.6%) 17 (7.7%)
Note:  aThree  levels  of  the  index  were  defined:  low  (Charlson  Index  Score), 
corresponding to patients with no underlying diseases implemented in the Charlson 
index, medium (Charlson index score 1–2), and high (Charlson index score .2).Clinical Epidemiology 2011:3 submit your manuscript | www.dovepress.com
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Table 2 Total numbers and relative risk (mortality rate ratio) of 30-day and 90-day mortality of 222 chronic obstructive pulmonary 
disease patients treated with invasive mechanical ventilation at silkeborg hospital, Denmark, 1994–2004
Mortality 
(n)
Mortality 
(%)
Crude risk MRR 
(95% CI)
Adjusted risk 
MRR (95% CI)*
30 days
  hb ,7.4 mmol/L (12.0 g/dL) 23 54.8 3.5 (1.8–6.6) 3.1 (1.6–5.9)
  hb 7.4–9.3 mmol/L (12–15 g/dL) 27 20.5 1 (Ref.) 1 (Ref.)
  hb .9.3 mmol/L (15.0 g/dL) 8 16.7 0.9 (0.4–2.1) 1.0 (0.4–2.4)
90 days
  hb ,7.4 mmol/L (12.0 g/dL) 24 57.1 3.0 (1.8–5.2) 2.6 (1.5–4.5)
  hb 7.4–9.3 mmol/L (12–15 g/dL) 33 25.0 1 (Ref.) 1 (Ref.)
  hb .9.3 mmol/L (15.0 g/dL) 11 22.9 0.9 (0.4–1.8) 1.1 (0.5–2.1)
Note: *Adjusted by Cox-proportional hazards regression analysis for gender, age, comorbidity, and ph at intensive care unit admission.
Abbreviations: hb, hemoglobin; MRR, mortality rate ratios.
A total of 13 patients in the low hemoglobin group and 
22 patients in the normal hemoglobin group had blood 
transfusions. Six patients received more than four units of 
blood. Restricting analyses to patients who did not receive 
blood transfusions revealed slightly increased MRRs (anemic 
COPD patients: adjusted 30-day MRR 3.7 [95% CI 1.9–7.0] 
and adjusted 90-day MRR 3.2 [95% CI 1.7–5.9]).
Discussion
In this follow-up study, including more than 200 COPD 
patients treated with invasive mechanical ventilation, we 
found that low hemoglobin levels were associated with 
substantially increased mortality within the first 90 days fol-
lowing admission. The association was found in both women 
and men and throughout the entire study period. Furthermore, 
it remained also after excluding patients who received blood 
transfusions, indicating that blood transfusion could not 
explain the increased mortality in anemic patients.
Anemia in critically ill ICU patients has been investigated 
in a number of studies, which demonstrate that anemia is a 
frequent phenomenon, and that a low hemoglobin level is 
well tolerated by most patients, with the possible exception 
of patients with ischemic heart disease.15,16 Furthermore, 
the use of blood transfusions in critical ill patients has been 
questioned because transfusions have been linked with 
increased mortality.15,16,20
We have not been able to identify available data on the 
relationship between anemia and clinical outcome specifi-
cally among critically ill COPD patients, which is a prob-
lem because a number of observational studies have found 
that anemia in stable patients with COPD is independently 
associated with increased mortality and morbidity.10–14,21 
The studies are not directly comparable because different 
definitions of anemia have been used, but the overall pattern 
of lower hemoglobin levels being associated with an adverse 
clinical outcome is consistently found. Anemia in patients 
with COPD appears to be associated with older age as well 
as a higher Charlson Comorbidity Index and Bode index 
compared with nonanemic and polycythemic patients with 
COPD.11 Our findings support the hypothesis that the possible 
adverse effects of anemia/low hemoglobin levels found in 
stable COPD patients also exist among critically ill COPD 
patients requiring invasive mechanical ventilation.
The main strengths of the present study include the avail-
ability of an unselected patient population (thus reducing the 
risk of selection and referral bias), the availability of clinical 
data which had been prospectively collected during routine 
clinical work independently of the study hypothesis, and the 
complete follow-up.
We relied on clinical findings by experienced physicians 
for diagnosing COPD in the majority of patients, who did 
not have a pulmonary function test done within one year 
of ICU admission, as is often done in observational stud-
ies on COPD.22 Signs and symptoms of heart failure and 
COPD overlap, so the cause for acute respiratory failure 
in an emergency setting can be difficult to diagnose. Their 
combined presence seems common but studies on the sub-
ject are scarce.23 Any misclassification of COPD patients 
was unlikely to be related to hemoglobin levels, and may 
therefore potentially have attenuated our relative mortality 
estimates toward unity.
As in any observational study, our study findings may 
potentially have been influenced by confounding factors. We 
controlled for a wide range of covariates in the data analyses, 
including demographics, comorbidity, and level of acidosis, 
none of which materially changed the association found. 
However, we lacked more detailed data on ICU treatment, 
including ventilator modality, and severity of COPD including 
FEV1, functional capacity, nutritional condition, and home 
oxygen requirements. We also had no   information regarding Clinical Epidemiology
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the etiology of the anemia. However, major bleeding was not 
a dominant cause because the majority of patients received 
less than four units of blood. The strict intubation policy 
for end-stage COPD patients in our department limited the 
number of these patients in our study. Still, we cannot entirely 
rule out the possibility that anemia was a marker of end-stage 
COPD, and therefore associated with increased mortality. 
Furthermore, a relatively large number of COPD patients was 
included in our study, although the statistical precision of the 
risk estimates was modest, in particular in the subanalyses. 
Finally, this was a single-institution study, and although the 
patient population and management practice at our ICU was 
probably comparable with that of many other departments in 
the same time period, some caution should be taken before 
generalizing the findings to other settings.
In conclusion, our study showed that anemia in critically 
ill COPD patients treated with invasive mechanical ventila-
tion was associated with substantially increased mortality. 
Further studies are needed to clarify whether increasing the 
hemoglobin level in critically ill patients with COPD to a 
higher level than is presently accepted for ICU patients in 
general will improve outcome.
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